| Trial ID: | L6467 |
| Source ID: | NCT00269061
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Non-Insulin-Dependent Diabetes Mellitus
|
| Interventions: |
DRUG: pioglitazone
|
| Outcome Measures: |
Primary: Changes in interstitial fluid volume in the lower extremities as measured by MRI. | Secondary: Assessments of other indicators of fluid volume changes, including labwork evaluation, fluid compartment volume measurement, direct measurement of the calf.
|
| Sponsor/Collaborators: |
Sponsor: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
32
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-01
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2008-10-16
|
| Locations: |
GSK Investigational Site, Belmont, Massachusetts, 02478, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00269061
|
